Lavipharm S.A (LAVI) — Tangible Net Worth Ratio
Lavipharm S.A (LAVI) has a Tangible Net Worth Ratio of 6.2% as of December 2024. This metric is calculated by deducting intangible assets (€49.68 Million) from net assets (€52.97 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Lavipharm S.A net assets for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Lavipharm S.A Tangible Net Worth Ratio (2022–2024)
This chart shows how Lavipharm S.A's Tangible Net Worth Ratio has changed across 3 annual periods from 2022 to 2024. As of December 2024, the ratio stands at 6.2%, reflecting net assets of €52.97 Million with intangible assets of €49.68 Million EUR. Also explore Lavipharm S.A net asset momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Lavipharm S.A (2022–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Lavipharm S.A from 2022 to 2024, covering 3 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see LAVI stock market capitalisation.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 6.2% | €52.97 Million | €49.68 Million | €125.48 Million | ▲ +10.3 pp |
| 2023 | -4.1% | €42.77 Million | €44.54 Million | €114.79 Million | ▲ +10.5 pp |
| 2022 | -14.7% | €40.28 Million | €46.20 Million | €114.17 Million | — |